Article Type
Changed
Display Headline
Comorbidities Linked to Multiple Sclerosis
Systematic review teases out top 5 conditions

Comorbidity with multiple sclerosis can impact diagnosis, disability progression, and quality of life, but there are substantial gaps in epidemiological knowledge of comorbidities, according to a systematic review of 249 studies that found a wide variability in study designs and reporting.

Researchers quantitatively assessed population-based studies and found:

• The 5 most prevalent comorbidities were depression, anxiety, hypertension, hyperlipidemia, and chronic lung disease.

• The most prevalent autoimmune diseases were thyroid disease and psoriasis.

• The most prevalent cancers were cervical, breast, and digestive system cancers.

Citation: Marrie RA, Cohen J, Stuve O, et al. A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: overview. Mult Scler. 2015;21(3):263-281.

 

References

Author and Disclosure Information

Publications
Topics
Legacy Keywords
MS and comorbidities
Author and Disclosure Information

Author and Disclosure Information

Systematic review teases out top 5 conditions
Systematic review teases out top 5 conditions

Comorbidity with multiple sclerosis can impact diagnosis, disability progression, and quality of life, but there are substantial gaps in epidemiological knowledge of comorbidities, according to a systematic review of 249 studies that found a wide variability in study designs and reporting.

Researchers quantitatively assessed population-based studies and found:

• The 5 most prevalent comorbidities were depression, anxiety, hypertension, hyperlipidemia, and chronic lung disease.

• The most prevalent autoimmune diseases were thyroid disease and psoriasis.

• The most prevalent cancers were cervical, breast, and digestive system cancers.

Citation: Marrie RA, Cohen J, Stuve O, et al. A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: overview. Mult Scler. 2015;21(3):263-281.

 

Comorbidity with multiple sclerosis can impact diagnosis, disability progression, and quality of life, but there are substantial gaps in epidemiological knowledge of comorbidities, according to a systematic review of 249 studies that found a wide variability in study designs and reporting.

Researchers quantitatively assessed population-based studies and found:

• The 5 most prevalent comorbidities were depression, anxiety, hypertension, hyperlipidemia, and chronic lung disease.

• The most prevalent autoimmune diseases were thyroid disease and psoriasis.

• The most prevalent cancers were cervical, breast, and digestive system cancers.

Citation: Marrie RA, Cohen J, Stuve O, et al. A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: overview. Mult Scler. 2015;21(3):263-281.

 

References

References

Publications
Publications
Topics
Article Type
Display Headline
Comorbidities Linked to Multiple Sclerosis
Display Headline
Comorbidities Linked to Multiple Sclerosis
Legacy Keywords
MS and comorbidities
Legacy Keywords
MS and comorbidities
Article Source

PURLs Copyright

Inside the Article